231 related articles for article (PubMed ID: 17118406)
21. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
Liu G; Wang B; Zhang J; Jiang H; Liu F
J Ethnopharmacol; 2009 Nov; 126(2):350-4. PubMed ID: 19703533
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
[TBL] [Abstract][Full Text] [Related]
23. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice.
Hishikawa K; Nakaki T; Fujita T
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):442-6. PubMed ID: 15499038
[TBL] [Abstract][Full Text] [Related]
24. Disodium ascorbyl phytostanyl phosphate reduces plasma cholesterol concentrations and atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Lukic T; Wasan KM; Zamfir D; Moghadasian MH; Pritchard PH
Metabolism; 2003 Apr; 52(4):425-31. PubMed ID: 12701053
[TBL] [Abstract][Full Text] [Related]
25. [Effect of PMTG on atherosclerotic lesion formation and expression of ICAM-1 and VCAM-1 in ApoE-deficient mice].
Fang W; Zhang HX; Wang LY; Qin YW; Wu Y; Wang W; Liu B
Zhongguo Zhong Yao Za Zhi; 2007 Jul; 32(13):1320-3. PubMed ID: 17879736
[TBL] [Abstract][Full Text] [Related]
26. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.
Pastore L; Belalcazar LM; Oka K; Cela R; Lee B; Chan L; Beaudet AL
Gene; 2004 Mar; 327(2):153-60. PubMed ID: 14980712
[TBL] [Abstract][Full Text] [Related]
27. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide.
Recalde D; Ostos MA; Badell E; Garcia-Otin AL; Pidoux J; Castro G; Zakin MM; Scott-Algara D
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):756-61. PubMed ID: 14751811
[TBL] [Abstract][Full Text] [Related]
28. Dietary coenzyme Q10 does not protect against cigarette smoke-augmented atherosclerosis in apoE-deficient mice.
Gairola CG; Howatt DA; Daugherty A
Free Radic Biol Med; 2010 Jun; 48(11):1535-9. PubMed ID: 20227489
[TBL] [Abstract][Full Text] [Related]
29. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
30. Effects of vitamin E on oxidative stress and atherosclerosis in an obese hyperlipidemic mouse model.
Hasty AH; Gruen ML; Terry ES; Surmi BK; Atkinson RD; Gao L; Morrow JD
J Nutr Biochem; 2007 Feb; 18(2):127-33. PubMed ID: 16781857
[TBL] [Abstract][Full Text] [Related]
31. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
[TBL] [Abstract][Full Text] [Related]
32. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
33. Heparin inhibits the production of matrix metalloproteinase-2 and improves atherosclerosis in LDL receptor-deficient mice.
Guo H; Xu F; Sun A; Liu L; Shi Y
Coron Artery Dis; 2010 Jan; 21(1):39-45. PubMed ID: 19940766
[TBL] [Abstract][Full Text] [Related]
34. Dried plums (prunes) reduce atherosclerosis lesion area in apolipoprotein E-deficient mice.
Gallaher CM; Gallaher DD
Br J Nutr; 2009 Jan; 101(2):233-9. PubMed ID: 18761779
[TBL] [Abstract][Full Text] [Related]
35. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
[TBL] [Abstract][Full Text] [Related]
36. Modulation of plasma lipid levels affects benzo[a]pyrene-induced DNA damage in tissues of two hyperlipidemic mouse models.
Curfs DM; Beckers L; Godschalk RW; Gijbels MJ; van Schooten FJ
Environ Mol Mutagen; 2003; 42(4):243-9. PubMed ID: 14673869
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice.
Yao R; Cheng X; Liao YH; Chen Y; Xie JJ; Yu X; Ding YJ; Tang TT
J Cardiovasc Pharmacol; 2008 Feb; 51(2):188-95. PubMed ID: 18287887
[TBL] [Abstract][Full Text] [Related]
38. Pomegranate byproduct administration to apolipoprotein e-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoprotein.
Rosenblat M; Volkova N; Coleman R; Aviram M
J Agric Food Chem; 2006 Mar; 54(5):1928-35. PubMed ID: 16506855
[TBL] [Abstract][Full Text] [Related]
39. Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice.
Navab M; Hama S; Hough G; Fogelman AM
Circulation; 2003 Oct; 108(14):1735-9. PubMed ID: 14504179
[TBL] [Abstract][Full Text] [Related]
40. [Effect of low doses of folic acid on selected biochemical atherosclerosis risk factors--preliminary study].
Mierzecki A; Bukowska H; Honczarenko K; Jastrzebska M; Naruszewicz M
Pol Merkur Lekarski; 2005 Jul; 19(109):57-62. PubMed ID: 16194028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
